NOVEL FUSION PROTEIN SPECIFIC FOR CD137 AND CD228 Application WO-2024064713-A1 World Intellectual Property Organisation (WIPO) 28 Mar 2024
Method for treating cancer using anti-CD137 antibody Grant US-11859003-B2 United States of America 02 Jan 2024